DAP:ETR
Danaher Corp
€210.60
0.00%
(0.00) 1D
Nov 16, 5:35:42 PM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DAP...
Mkt. cap
161.75B
Avg. vol.
520.00
Volume
0.00
52-wk high
€214.50
52-wk low
€138.20
No. of employees
59K
Mkt. cap
161.75B
Avg. vol.
520.00
Volume
0.00
52-wk high
€214.50
52-wk low
€138.20
No. of employees
59K
News stories
From web sources and news partners
Yahoo Finance
·
1 hour ago
Stock Market: Will S&P 500 Open Up or Down Today?
The Motley Fool
·
16 hours ago
Is an Equal-Weight S&P 500 Fund Safer Right Now Than the One You Own?
ChartMill
·
14 hours ago
Today's S&P 500 Top Movers: Tyson Foods Leads Gainers, Lumentum Leads Decliners
Traders Union
·
8 hours ago
Michael A. Gayed: S&P 500 fell 19.35% and high yield dropped 5.9% in Q4 2018 selloff
Profile
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing.
The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000. Wikipedia
About Danaher Corp